[DJR-159 1.0 CE – available until 12/1/2023] Thrombotic Risk Associated with Inferior Vena Cava Filter Placement in Patients with Heparin-Induced Thrombocytopenia

Purpose: This study sought to define thromboembolic risk and mortality in patients with heparin-induced thrombocytopenia (HIT) undergoing inferior vena cava filter (IVCF) placement, in light of the American Society of Hematology’s 2018 guidelines against routine use of IVCFs in this population.
Methods: A total of 26 patients with HIT who received IVCFs were retrospectively reviewed, and the outcomes of this group were compared with those of 4,707 controls with either HIT or IVCFs alone and with reported outcomes in prior studies.
Results: The patient group demonstrated 6- and 12-month mortality rates of 26.9% and 30.8%, respectively, which did not differ significantly from those of the control groups and were in line with published mortality rates in the literature. The measured throm-
boembolic risk of 19.2% in the patient group was also within the range of published rates for patients with HIT or IVCF alone.
Conclusions: IVCF placement did not significantly increase the risk of thromboembolism or death in patients with HIT and may be a
viable option in the subset of these patients who are not candidates for anticoagulation.